Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tardio Jason
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rona Jeffrey A
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Poole Robert Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perone Thomas Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedman Bart
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Kevin Joseph
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Karen
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeremy M. Levin(9.4%)
Ovid Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer LEVIN JEREMY M
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Madison Avenue International LP(5.2%),Madison Avenue Partners, LP(5.2%), etc.
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(7.52%),David Rosen(7.52%)
Ovid Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.1%)
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-CEO LEVIN JEREMY M
Ovid Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Madison Avenue International LP(5.1%),Madison Avenue Partners, LP(5.1%), etc.
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data